title: Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media.
abstract: BACKGROUND
  Streptococcus pneumoniae is a major bacterial pathogens in acute otitis media. Pneumolysin is a species-specific protein toxin produced intracellularly by all clinically relevant pneumococcal strains, and antibodies to pneumolysin should therefore represent pneumococcal involvement in the disease, regardless of the serotype.
  
  
  METHODS
  Antibodies to pneumococcal pneumolysin and capsular polysaccharides were measured by enzyme immunoassay in acute and convalescent sera of 121 children with acute otitis media. A pneumococcal otitis episode was defined by a positive middle ear fluid culture and/or pneumolysin PCR.
  
  
  RESULTS
  Median age of the 10 children who developed a seroconversion response to pneumolysin was 1 year 8 months, and of the 21 children responding to polysaccharides it was 2 years 9 months. Eight of the 10 seroconversion responses to pneumolysin were of IgA class alone, whereas 17 of the 21 polysaccharide responses were of IgG class alone or IgG together with IgM and/or IgA. Of the 41 children with a pneumococcal otitis episode, 13 (39%) showed a seroconversion response, 3 (7%) to pneumolysin and 11 (27%) to capsular polysaccharides. The children with a pneumococcal otitis episode had lower titers of acute phase IgG to the capsular polysaccharide pool of S. pneumoniae (containing types 6B, 14, 19F and 23F), as compared with the titers in children with otitis caused by other pathogens and pneumococci only in the nasopharynx or not found at all (P = 0.04).
  
  
  CONCLUSIONS
  Serum antibodies to pneumolysin can be detected at an earlier age than those to the capsular polysaccharides. However, a seroconversion is rare and therefore of no diagnostic value. The presence of serum IgG to the pneumococcal capsular polysaccharides seems beneficial in the prevention of pneumococcal otitis.
authors.affiliation: National Public Health Institute, Helsinki, Finland.
authors.forename: A
authors.initials: A
authors.lastname: Virolainen
authors.forename: J
authors.initials: J
authors.lastname: Jero
authors.forename: P
authors.initials: P
authors.lastname: Chattopadhyay
authors.forename: P
authors.initials: P
authors.lastname: Karma
authors.forename: J
authors.initials: J
authors.lastname: Eskola
authors.forename: M
authors.initials: M
authors.lastname: Leinonen
mesh_terms: D000208:Acute Disease; D000704:Analysis of Variance; D000907:Antibodies, Bacterial / Q000032:analysis*; D001426:Bacterial Proteins; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D008297:Male; D010033:Otitis Media / Q000097:blood / Q000276:immunology*; D011008:Pneumococcal Infections / Q000097:blood / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000032:analysis*; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000276:immunology*; D013301:Streptolysins / Q000032:analysis*
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011135:Polysaccharides, Bacterial; D013301:Streptolysins; C032290:plY protein, Streptococcus pneumoniae